Pentadecapeptide BPC (Oral)
Also known as: Oral BPC-157
Oral BPC-157 refers to stabilized oral preparations of the pentadecapeptide Body Protection Compound-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), most commonly the arginate salt (sometimes acetate or enteric-coated capsules), intended to survive gastric transit and improve absorption versus the unformulated peptide. This entry covers the salt/stabilized formulations specifically; generic BPC-157 capsules without a salt-form claim are classified under the base BPC-157 entry.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
No COAs on file for Pentadecapeptide BPC (Oral)
No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.